Credit Suisse Ag Bristol Myers Squibb CO Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Credit Suisse Ag holds 4,884,813 shares of BMY stock, worth $282 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

4,884,813

Previous 6,678,731 26.86%

Holding current value

$282 Million

Previous $343 Million 22.7%

% of portfolio

0.26%

Previous 0.34%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$47.98 - $54.4 $86.1 Million - $97.6 Million	-1,793,918 Reduced 26.86%	4,884,813 $265 Million
Q4 2023 Feb 08, 2024	BUY	$48.48 - $57.85 $24.8 Million - $29.6 Million	510,808 Added 8.28%	6,678,731 $343 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $19.8 Million - $22.1 Million	341,884 Added 5.87%	6,167,923 $358 Million
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $16.7 Million - $18.5 Million	261,652 Added 4.7%	5,826,039 $373 Million
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $10.7 Million - $12.1 Million	162,687 Added 3.01%	5,564,387 $386 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $39.8 Million - $47.1 Million	581,111 Added 12.05%	5,401,700 $389 Million
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $16,762 - $9.91 Million	128,943 Added 2.75%	4,820,589 $343 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $28.7 Million - $31.6 Million	395,009 Added 9.19%	4,691,646 $361 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $13.5 Million - $16.1 Million	218,972 Added 5.37%	4,296,637 $314 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $1.31 Million - $1.53 Million	-24,437 Reduced 0.6%	4,077,665 $254 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $15 Million - $17.6 Million	-253,890 Reduced 5.83%	4,102,102 $243 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $14.7 Million - $16.1 Million	-238,150 Reduced 5.18%	4,355,992 $289 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $13 Million - $14.6 Million	-219,402 Reduced 4.56%	4,594,142 $290 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $26.7 Million - $30.3 Million	-462,329 Reduced 8.76%	4,813,544 $299 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $14.7 Million - $16.2 Million	255,156 Added 5.08%	5,275,873 $318 Million
Q2 2020 Aug 12, 2020	SELL	$54.82 - $64.09 $74.1 Million - $86.7 Million	-1,352,157 Reduced 21.22%	5,020,717 $295 Million
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $204 Million - $297 Million	-4,401,812 Reduced 40.85%	6,372,874 $355 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $12.9 Million - $16.8 Million	261,309 Added 2.49%	10,774,686 $692 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $58.7 Million - $69.6 Million	-1,372,851 Reduced 11.55%	10,513,377 $533 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $370 Million - $409 Million	8,281,100 Added 229.7%	11,886,228 $539 Million
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $149 Million - $177 Million	-3,298,923 Reduced 47.78%	3,605,128 $172 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $184 Million - $238 Million	3,765,188 Added 119.95%	6,904,051 $359 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $3.63 Million - $4.1 Million	-65,862 Reduced 2.06%	3,138,863 $195 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $2.82 Million - $3.52 Million	55,841 Added 1.77%	3,204,725 $177 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $49.3 Million - $56.8 Million	-822,852 Reduced 20.72%	3,148,884 $199 Million
Q4 2017 Mar 14, 2018	BUY	$59.94 - $65.35 $711,907 - $776,161	11,877 Added 0.3%	3,971,736 $243 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $3.79 Million - $4.13 Million	63,178 Added 1.62%	3,959,859 $243 Million
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $3.47 Million - $4 Million	-62,801 Reduced 1.59%	3,896,681 $248 Million
Q2 2017 Aug 14, 2017	BUY	N/A	3,959,482	3,959,482 $225 Million

Others Institutions Holding BMY

# of Institutions

2,537

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account